Filters: Keyword is Anti-HIV Agents [Clear All Filters]
"Public health implications for adequate transitional care for HIV-infected prisoners: five essential components." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 53, no. 5 (2011): 469-79. Abstract
"Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements." AIDS (London, England) 23, no. 16 (2009): 2199-208. Abstract
"Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana." AIDS and behavior 15, no. 6 (2011): 1121-7. Abstract
"Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS." AIDS patient care and STDs 23, no. 6 (2009): 449-54. Abstract
"Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project." Journal of acquired immune deficiency syndromes (1999) 30, no. 3 (2002): 311-5. Abstract
"A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China." AIDS and behavior 15, no. 5 (2011): 919-29. Abstract
"Preexposure chemoprophylaxis for HIV prevention." The New England journal of medicine 364, no. 14 (2011): 1374; author reply 1374-5.
"Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical pharmacokinetics 44, no. 1 (2005): 99-109. Abstract
"The place of prevention in HIV clinical care: a roundtable discussion." AIDS clinical care 14, no. 6 (2002): 49-53, 58.
"A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting." Journal of acquired immune deficiency syndromes (1999) 36, no. 4 (2004): 929-34. Abstract
"A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)." AIDS research and human retroviruses 18, no. 10 (2002): 699-704. Abstract
"The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 1 (2002): 66-74. Abstract
"Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract
"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
"Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 50, no. 2 (2009): 176-81. Abstract
"Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America." AIDS (London, England) 26, no. 11 (2012): 1415-23. Abstract
"Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir." AIDS patient care and STDs 26, no. 6 (2012): 312-9. Abstract
"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
"Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients." Antiviral therapy 10, no. 1 (2005): 41-52. Abstract
"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S91-7. Abstract
"Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica." AIDS patient care and STDs 18, no. 5 (2004): 297-304. Abstract
"Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine." American journal of preventive medicine 44, no. 1 Suppl 2 (2013): S86-90.
"Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies." PLoS medicine 11, no. 9 (2014): e1001718. Abstract
"Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity." HIV clinical trials 9, no. 5 (2008): 298-308. Abstract
"Models for integrating buprenorphine therapy into the primary HIV care setting." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42, no. 5 (2006): 716-21. Abstract
"Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america." American journal of epidemiology 174, no. 6 (2011): 727-35. Abstract
"Misinterpretation of HIV preexposure prophylaxis findings." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 59, no. 1 (2014): 139-41.
"Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 46, no. 6 (2008): 941-5. Abstract
"Meeting report from the XV International AIDS Conference. Adherence." AIDS clinical care 16, no. 9 (2004): 74-5.
"Meeting report from the XV International AIDS Conference. Access in the developing world." AIDS clinical care 16, no. 9 (2004): 69-70.
"Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy." AIDS and behavior 17, no. 1 (2013): 113-21. Abstract
"Medical interventions for addictions in the primary care setting." Topics in HIV medicine : a publication of the International AIDS Society, USA 18, no. 1 (2010): 8-12. Abstract
"Managing multiple and extensively drug-resistant tuberculosis and HIV." Expert opinion on pharmacotherapy 8, no. 8 (2007): 1035-7. Abstract
"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 58, no. 9 (2014): 1312-21. Abstract
"Is it time for treatment as prevention among people who inject drugs?" Journal of acquired immune deficiency syndromes (1999) 63, no. 5 (2013): 545-7.
"Involving behavioral scientists, health care providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S10-7. Abstract
"Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16, no. 8 (2012): 998-1004. Abstract
"Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission." American journal of public health 101, no. 3 (2011): 531-8. Abstract
"Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration." Journal of acquired immune deficiency syndromes (1999) 69, no. 3 (2015): 348-54. Abstract
"Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy." AIDS and behavior 12, no. 2 (2008): 284-93. Abstract
"The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample." AIDS and behavior 13, no. 1 (2009): 66-75. Abstract
"The information-motivation-behavioral skills model of antiretroviral adherence and its applications." Current HIV/AIDS reports 5, no. 4 (2008): 193-203. Abstract
"Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model." Annals of internal medicine 148, no. 3 (2008): 178-85. Abstract
"Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age." The Pediatric infectious disease journal 30, no. 10 (2011): 877-82. Abstract
"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression." Journal of acquired immune deficiency syndromes (1999) 52, no. 2 (2009): 203-8. Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Implementation science of pre-exposure prophylaxis: preparing for public use." Current HIV/AIDS reports 7, no. 4 (2010): 210-9. Abstract
